Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Goiânia, Brazil

Vaccine

Volumn 30, Issue 10, 2012, Pages 1901-1909

  Andrade, Ana Lucia ^a   Oliveira, Renato ^a   Vieira, Maria A ^a   Minamisava, Ruth ^a   Pessoa, Vicente ^a   Brandileone, Maria Cristina C ^b   Alves, Sueli L A ^c   Alfieri, Fernando ^d   Pagliarini, Rosana ^d   Moraes, José Cassio ^e   Gray, Sharon ^d   Rodgers, Gail L ^d  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c Secretariat of Health of Goiás State   (Brazil)

^d PFIZER INC   (United States)

^e Santa Casa School of Medical Sciences   (Brazil)

Author keywords

Pneumococcal conjugate vaccines; Pneumococcal infections; Pneumococcal pneumonia; Population based incidence; Streptococcus pneumoniae

Indexed keywords

PENICILLIN G; PNEUMOCOCCUS VACCINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL LOAD; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM ISOLATE; BLOOD SAMPLING; BRAZIL; CEREBROSPINAL FLUID; CHILD; CHILD HOSPITALIZATION; CHILDHOOD DISEASE; CLINICAL ASSESSMENT; DISEASE SURVEILLANCE; EMERGENCY WARD; FEMALE; HUMAN; HUMAN TISSUE; INCIDENCE; INFANT; INVASIVE PNEUMOCOCCAL DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; OUTPATIENT DEPARTMENT; PEDIATRIC HOSPITAL; PLEURA FLUID; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; PNEUMONIA; POLYMERASE CHAIN REACTION; POPULATION BASED CASE CONTROL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; THORAX RADIOGRAPHY; VACCINATION;

BRAZIL; CHILD, PRESCHOOL; FEMALE; HUMANS; INCIDENCE; INFANT; MALE; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; PNEUMONIA, BACTERIAL; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES;

EID: 84857447822     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.12.012     Document Type: Article

References (46)

1. World Health Organization Immunization, vaccines and biologicals global immunization vision and strategy 2011, June, http://www.who.int/immunization/givs/en/.
2. Lagos R., Muñoz A., Valenzuela M.T., Heitmann I., Levine M.M. Population-based surveillance for hospitalized and ambulatory pediatric invasive pneumococcal disease in Santiago, Chile. Pediatr Infect Dis J 2002, 21(12):1115-1123.
3. Reis J.N., Cordeiro S.M., Coppola S.J., Salgado K., Carvalho M.G., Teixeira L.M., et al. Population-based survey of antimicrobial susceptibility and serotype distribution of Streptococcus pneumoniae from meningitis patients in Salvador, Brazil. J Clin Microbiol 2002, 40(1):275-277.
4. Ulloa-Gutierrez R., Avila-Aguero M.L., Herrera M.L., Herrera J.F., Arguedas A. Invasive pneumococcal disease in Costa Rican children: a seven year survey. Pediatr Infect Dis J 2003, 22(12):1069-1074.
5. Tregnaghi M., Ceballos A., Rüttimann R., Ussher J., Tregnaghi P., Peeters P., et al. Active epidemiologic surveillance of pneumonia and invasive pneumococcal disease in ambulatory and hospitalized infants in Cordoba, Argentina. Pediatr Infect Dis J 2006, 25(4):370-372.
6. Inostroza J., Illesca V., Reydet P., Vinet A.M., Ossa G., Muñoz S., et al. Ten-year surveillance of pneumococcal infections in Temuco, Chile: implications for vaccination strategies. Clin Vaccine Immunol 2007, 14(6):660-664.
7. SIREVA. Pan American Health Organization. Informe Regional de SIREVA II: Datos por país y por grupos de edad sobre las características de los aislamientos de Streptococcus pneumoniae, Haemophilus influenzae y Neisseria meningitidis, en procesos invasores, 2006. Documentos Técnicos, Tecnologías Esenciales de Salud. THR/EV. 2008/001. Pan American Health Organization. /44B1956F-3F7C-45D3-A366-DBA8B1D57217/FinalDownload/DownloadId-E8D2804067355B49A47646D29DCED750/44B1956F-3F7C-45D3-A366-DBA8B1D57217/spanish/AD/THS/EV/labs_Sireva_II_2006.pdf. http://www.paho.org/.
8. World Health Organization acute respiratory infections in children: case management in small hospitals in developing countries, WHO/ARI/90.5 1990, WHO, Geneva, Switzerland.
9. Obaro S.K., Madhi S.A. Bacterial pneumonia vaccines and childhood pneumonia: are we winning, refining, or redefining?. Lancet Infect Dis 2006, 6(3):150-161.
10. World Health Organization Standardization of interpretation of chest radiographs for the diagnosis of pneumonia in children 2001, World Health Organization Pneumonia Vaccine Trial Investigators' Group, http://www.who.int/vaccines-documents/DocsPDF01/www616.pdf.
11. Mani C.S., Murray D.L. Acute pneumonia and its complications. Principles and Practice of Pediatric Infectious Diseases 2008, 245-253. Elsevier, Philadelphia, PA. third ed. S.S. Long, L.K. Pickering, C.G. Prober (Eds.).
12. Bogaert D., De Groot R., Hermans P.W. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect Dis 2004, 4(3):144-154.
13. Juvén T., Mertsola J., Waris M., Leinonen M., Meurman O., Roirainen M., et al. Etiology of community-acquired pneumonia in 254 hospitalized children. Pediatr Infect Dis J 2000, 19(4):293-298.
14. Michelow I.C., Olsen K., Lozano J., Rollins N.K., Duffy L.B., Zeigler T., et al. Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children. Pediatrics 2004, 113(4):701-707.
15. Forgie I.M., O'Neill K.P., Lloyd-Evans N., Leinonen M., Campbell H., Whittle H.C., et al. Etiology of acute lower respiratory tract infections in Gambian children: II acute lower respiratory tract infection in children ages one to nine years presenting at the hospital. Pediatr Infect Dis J 1991, 10(1):42-47.
16. Rapkin R.H. Bacteriologic and clinical findings in acute pneumonia of childhood. Clin Pediatr (Phila) 1975, 14(2):130-133.
17. Shann F., Gratten M., Germer S., Linnemann V., Hazlett D., Payne R. Aetiology of pneumonia in children in Goroka Hospital, Papua New Guinea. Lancet 1984, 2(8402):537-541.
18. Clinical Laboratory Standards Institute Clinical laboratory standards institute standard for susceptibility testing 2007, vol. 27. Number 2, MII-A7.
19. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; 19th informational supplement. Approved standard. CLSI document M100-19. Wayne, PA, USA, CLSI; 2009.
20. da Gloria Carvalho M., Pimenta F.C., Jackson D., Roundtree A., Ahmad Y., Millar E.V., et al. Revisiting pneumococcal carriage by use of broth enrichment and PCR techniques for enhanced detection of carriage and serotypes. J Clin Microbiol 2010, 48(5):1611-1618.
21. Daly L. Simple SAS macros for the calculation of exact binomial and Poisson confidence limits. Comput Biol Med 1992, 22(5):351-361.
22. Instituto Brasileiro de Geografia e Estatística (IBGE). Censo Demográfico 2000. http://www.ibge.gov.br/home/estatistica/populacao/censo2000/.
23. Brazilian Ministry of Health, Datasus. Informações de Saúde, (in Portuguese). http://tabnet.datasus.gov.br/cgi/deftohtm.exe%3Fpni/cnv/dpnibr.def.
24. Garcia S., Levine O.S., Cherian T., Gabastou J.M., Andrus J. Pneumococcal disease and vaccination in the Americas: an agenda for accelerated vaccine introduction. Rev Panam Salud Publica 2006, 19(5):340-348. Working Group Members.
25. Abarca V.K., Vergara F.R., Tassara P.E., Ibáñez W.I., Garcia B.C., Potin S.M. Invasive pneumococcal disease and consolidated pneumonia in infants: one year of surveillance in three chilean health care centers. Rev Chilena Infectol 2008, 25(2):97-103. [In Spanish].
26. Victora C.G., Kirkwood B.R., Ashworth A., Black R.E., Rogers S., Sazauwal S., et al. Potential interventions for the prevention of childhood pneumonia in developing countries: improving nutrition. Am J Clin Nutr 1999, 70(3):309-320.
27. Hortal M., Estevan M., Iraola I., De Mucio B. A population-based assessment of the disease burden of consolidated pneumonia in hospitalized children under five years of age. Int J Infect Dis 2007, 11(3):273-277.
28. Klugman K.P., Madhi S.A., Huebner R.E., Kohberger R., Mbelle N., Pierce N., et al. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003, 349(14):1341-1348.
29. Black S., Shinefield H., Fireman B., Lewis E., Ray P., Hansen J.R., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group. Pediatr Infect Dis J 2000, 19(3):187-195.
30. Cutts F.T., Zaman S.M., Enwere G., Jaffars S., Levine O.S., Okoko J.B., et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 2005, 365(9465):1139-1146.
31. Lucero M.G., Nohynek H., Williams G., Tallo V., Simões E.A., Lupisan S., et al. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial. Pediatr Infect Dis J 2009, 28(6):455-462.
32. COMPAS: a phase III study to demonstrate efficacy of GlaxoSmithKline Biologicals' 10-valent pneumococcal vaccine (GSK1024850A) against Community Acquired Pneumonia and Acute Otitis Media: GSK1024850A - Synflorix™ (10Pn): GlaxoSmithKline (GSK) Biologicals' 10-valent pneumococcal vaccine. Study No:109563 (10PN-PD-DIT-028). http://download.gsk-clinicalstudyregister.com/files/09bc28e7-ee05-4fec-b363-f84024992979.
33. Brundage J.F. Interactions between influenza and bacterial respiratory pathogens: implications for pandemic preparedness. Lancet Infect Dis 2006, 6(5):303-312.
34. Chien Y.W., Klugman K.P., Morens D.M. Bacterial pathogens and death during the 1918 influenza pandemic. N Engl J Med 2009, 361(26):2582-2583.
35. McCullers J.A., Rehg J.E. Lethal synergism between influenza virus and Streptococcus pneumoniae: characterization of a mouse model and the role of platelet-activating factor receptor. J Infect Dis 2002, 186(3):341-350.
36. Simonsen L., Taylor R.J., Young-Xu Y., Haber M., May L., Klugman K.P. Impact of pneumococcal conjugate vaccination of infants on pneumonia and influenza hospitalization and mortality in all age groups in the United States. MBio 2011, 2(1):e00309-e310.
37. Lagos R.M., Muñoz A.E., Levine MM Prevalence of pneumococcal bacteremia among children <36 months of age presenting with moderate fever to pediatric emergency rooms of the Metropolitan Region (Santiago), Chile. Hum Vaccin 2006, 2(3):129-133.
38. Andrade A.L., Silva S.A., Martelli C.M., Oliveira R.M., Morais Netool, Siqueira Júnior J.B., et al. Population-based surveillance of pediatric pneumonia: use of spatial analysis in an urban area of Central Brazil. Cad Saude Publica 2004, 20(2):411-421.
39. Thörn L.K., Minamisava R., Nouer S.S., Ribeiro L.H., Pneumonia Andrade A.L. poverty: a prospective population-based study among children in Brazil. BMC Infect Dis 2011, 11:180.
40. Laval C.B., de Andrade A.L., Pimenta F.C., de Andrade J.G., de Oliveira R.M., Silva S.A., et al. Serotypes of carriage and invasive isolates of Streptococcus pneumoniae in Brazilian children in the era of pneumococcal vaccines. Clin Microbiol Infect 2006, 12(1):50-55.
41. Berezin E.N., Cardenuto M.D., Ferreira L.L., Otsuka M., Guerra M.L., Brandileone M.C. Distribution of Streptococcus pneumoniae serotypes in nasopharyngeal carriage and in invasive pneumococcal disease in Sao Paulo, Brazil. Pediatr Infect Dis J 2007, 26(7):643-645.
42. Brandileone M.C., Vieira V.S., Casagrande S.T., Zanella R.C., Guerra M.L., Bokermann S., et al. Prevalence of serotypes and antimicrobial resistance of Streptococcus pneumoniae strains isolated from Brazilian children with invasive infections. Pneumococcal Study Group in Brazil for the SIREVA Project. Regional Systems for Vaccines in Latin America. Microb Drug Resist 1997, 3(2):141-146.
43. Hausdorff W.P. The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease. Vaccine 2007, 25(13):2406-2412.
44. Agudelo C.I., Castañeda E., Corso A., Regueira M., Brandileone M.C., Brandão A.P., et al. Resistance to non-beta-lactam antibiotics in the clinical isolates of Streptococcus pneumoniae of children in Latin America. SIREVA II, 2000-2005. Rev Panam Salud Publica 2009, 25(4):305-313. [In Spanish].
45. Instituto Brasileiro de Geografia e Estatística (IBGE) Per capita income. Goiânia, Brazil 2005, http://www.ibge.gov.br/home/estatistica/economia/pibmunicipios/2005/tab01.pdf.
46. Instituto Brasileiro de Geografia e Estatistica (IBGE) Population Census 2010, http://www.ibge.gov.br/english/estatistica/populacao/censo2010/default.shtm.